The Thermoanaerobacter ethanolicus 39E adhB gene encoding the secondary-alcohol dehydrogenase (2m ADH) was overexpressed in Escherichia coli at more than 10 % of total protein. The recombinant enzyme was purified in high yield (67 %) by heat-treatment at 85 mC and (NH % ) # SO % precipitation. Sitedirected mutants (C37S, H59N, D150N, D150E and D150C were analysed to test the peptide sequence comparison-based predictions of amino acids responsible for putative catalytic Zn binding. X-ray absorption spectroscopy confirmed the presence of a protein-bound Zn atom with ZnS " (imid) " (N,O) $ co-ordination sphere. Inductively coupled plasma atomic emission spectrometry measured 0n48 Zn atoms per wild-type 2m ADH subunit. The C37S, H59N and D150N mutant enzymes bound only 0n11, 0n13 and 0n33 Zn per subunit respectively, suggesting that these residues are involved in Zn liganding. The D150E and D150C mutants retained 0n47 and 1n2 Zn atoms per subunit, indicating that an anionic side-chain moiety at this position preserves the bound Zn. All five mutant enzymes had 3 % of wild-type
INTRODUCTION
Alcohol dehydrogenases (ADHs), central to prokaryotic and eukaryotic metabolism, are also potential biocatalysts for chiral chemical production [1] [2] [3] [4] [5] [6] . The functionally and presumably structurally similar ADHs are classified as primary or secondary based on their higher catalytic efficiencies toward primary (1m) or secondary (2m) alcohols. These typically homodimeric or homotetrameric enzymes are almost exclusively Zn-containing metalloenzymes [7] that use NAD(H) (EC 1;1;1;1), NADP(H) (EC 1;1;1;2) or both (EC 1;1;1;71) as cofactor. Fe-linked [8] and ferredoxin F #%! -dependent [9] 1m ADHs have also been reported. The catalytic role of Zn in liver 1m ADH activity has been proposed to involve binding directly to the substrate oxygen atom, facilitating hydride transfer between the adjacent substrate carbon atom and the nicotinamide cofactor [7, [10] [11] [12] . Although 1m ADHs from diverse sources have been extensively characterized [7] , little is known about the molecular basis for their substrate specificity. Far less is known about 2m ADH structure-function, with relatively few reported studies on enzyme purification and characterization [13] [14] [15] [16] [17] and a complete lack of site-directed mutagenic information. Recent reports of thermophilic and mesophilic 2m ADH crystallization and X-ray diffraction [18] [19] [20] provide the promise of exact structural data ;
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catalytic activity, suggesting that the T. ethanolicus 2m ADH requires a properly co-ordinated catalytic Zn atom. The His-59 and Asp-150 mutations also altered 2m ADH affinity for propan-2-ol over a 140-fold range, whereas the overall change in affinity for ethanol spanned a range of only 7-fold, supporting the importance of the metal in 2m ADH substrate binding. The lack of significant changes in cofactor affinity as a result of these catalytic Zn ligand mutations suggested that 2m ADH substrateand cofactor-binding sites are structurally distinct. Altering Gly"*) to Asp reduced the enzyme specific activity 2.7-fold, increased the K m (app) for NADP + 225-fold, and decreased the K m (app) for NAD + 3-fold, supporting the prediction that the enzyme binds nicotinamide cofactor in a Rossmann fold. Our data indicate therefore that, unlike the liver 1m ADH, the Rossmann-fold-containing T. ethanolicus 2m ADH binds its catalytic Zn atom using a sorbitol dehydrogenase-like Cys-HisAsp motif and does not bind a structural Zn atom.
however, the inability of structural characterization alone to explain 1m ADH catalytic properties underscores the importance of a multidisciplinary approach to 2m ADH structure-function research. Because of the central metabolic roles of 2m ADHs [17, 21] and their potential biotechnological value [1] [2] [3] [4] [5] [6] 22, 23] , structure-function analysis of catalysis and substrate specificity would contribute significantly to the basic understanding of enzyme function and to biocatalyst design. The exact three-dimensional structure of horse liver 1m ADH has been determined [24] , indicating that the catalytic Zn atom is bound by two Cys and one His residue and that the nicotinamide cofactor is bound in a Rossmann fold [7, 25] . Research to date has failed to identify the ADH active-site residues specifically responsible for substrate binding. The presumed similarity, based on shared catalytic properties, between 1m and 2m ADH structures provided the rationale for sequence-based comparisons between these enzymes [26] [27] [28] . Peptide sequence alignments of thermophilic and mesophilic 1m and 2m ADHs were used to hypothesize (i) that 2m ADHs bind their nicotinamide cofactor in a Rossmann fold, (ii) that they lack a structural Zn-binding loop, and (iii) that they use a unique Cys-His-Asp (Cys$(-His&*-Asp"&!) motif for catalytic metal liganding [28] . Chemical-modification experiments have implicated Zn, Cys and His in Thermoanaerobium brockii and Thermoanaerobacter ethanolicus 39E 2m ADH ca-talysis [13, 28] , but validation of the predicted Zn-liganding motif awaited assessment by biophysical characterization and sitedirected mutagenesis. The strong similarities among 2m ADH peptide sequences, kinetic parameters, subunit compositions and molecular masses [28, 29] suggest that the results of the T. ethanolicus 2m ADH structure-function analysis will be generally applicable to other 2m ADHs.
The research reported here involves the development of a recombinant overexpression and purification system providing high yields of homogeneous enzyme. The roles of T. ethanolicus 2m ADH amino acids Cys$(, His&* and Asp"&! as catalytic Znbinding ligands and of Gly"*) as the single residue responsible for NADP(H) specificity are assessed from site-directed mutation effects on enzyme K m (app), V max (app), Zn and cofactor binding. X-ray absorption spectroscopic (XAS) studies support this catalytic Zn-co-ordination sphere. Finally, kinetic data on 2m ADH mutants and exact structural information on 1m ADHs are used to create a hypothetical working model for the 2m ADH active site and to distinguish key differences between 2m and 1m ADH structure-function relationships.
MATERIALS AND METHODS

Chemicals and reagents
All chemicals were reagent\molecular biology grade or purer. Oligonucleotide synthesis and amino acid sequence analysis were performed by the Macromolecular Structure Facility, Department of Biochemistry, Michigan State University. The kanamycin-resistance GenBlock (EcoRI) DNA cartridge used in expression vector construction was purchased from Pharmacia (Uppsala, Sweden) [30] . DNA for sequencing was isolated using the Wizard Miniprep kit (Promega, Madison, WI, U.S.A.).
Media and strains
Escherichia coli (DH5α) containing the 2m ADH recombinant plasmids were grown in rich complex medium (20 g\l tryptone, 10 g\l yeast extract, 5 g\l NaCl) at 37 mC in the presence of 25 µg\ml kanamycin and 100 µg\ml ampicillin.
Mutagenesis
All DNA manipulations were performed using established protocols [31, 32] . Point mutations were introduced into the T. ethanolicus 39E adhB gene by PCR [31] using plasmid pADHB25-kan [28] as template. An oligonucleotide primer (KA4N) was synthesized complementary to the non-coding strand that included a KpnI restriction site, the native adhB ribosome assembly site, and the adhB translation initiation codon (5h-CGGGGTACCCCGT-ATTTTAGGAGGTGTTTAATGATGAAAGG-3h). A second oligonucleotide primer (KA4C) that included the complement to the adhB termination codon and an ApaI restriction site (5h-CAGTCCGGGCCCTTATGCTAATATTACAACAG-GTTTG-3h) was synthesized complementary to the coding strand. Oligonucleotide 1M1N was identical with primer KA4N except for the substitution of TTA for ATG at positions 31-33. Complementary 30-45-base oligonucleotide primers that contained the mutated bases (C37S : coding, 5h-GCTGTGGCCC-CTTCCACTTCGGACATTCATACC-3h, non-coding, 5h-GGT-ATGAATGTCCGAAGTGGAAGGGGC-3h ; H59N : coding, 5h-CATGATACTCGGTAACGAAGCTGTA-3h, non-coding, 5h-CTTCACCTACAGCTTCGTTACCGAG-3h ; D150N : coding, 5h-GGAAGCTGCACTTATGATTCCCAATATGATGA-CCACTGG-3h ; non-coding, 5h-GCTCCGTGAAAACCAGTG-GTCATCATATTGGGAATCATA-3h ; D150C : coding, 5h-GG-AAGCTGCACTTATGATTCCCTGTATGATGACCACTGG3h, non-coding, 5h-GCTCCGTGAAAACCAGTGGTCATCA-TACAGGGAATCATAAG-3h ; D150E : coding, 5h-GGAAG-CTGCACTTATGATTCCCGAAATGATGACCACTGG-3h, non-coding, 5h-GCTCCGTGAAAACCAGTGGTCATCATT-TCGGGAATCATA-3h ; G198D : coding, 5h-GAATTATTGC-CGTAGACAGTAGACCAGTTTGTG-3h, non-coding, 5h-CA-CAAACTGGTCTACTGTCTACGGCAATAATTC-3h) were used in conjunction with the two KA4 end primers to amplify the N-terminal and C-terminal segments of the adhB gene. PCR syntheses of partial and complete mutated genes were performed using the Taqplus exonuclease-containing polymerase reagent (Strategene, LA Jolla, CA, U.S.A.). All clones were expressed in pBluescriptII KS(j) containing a kanamycin-resistance cartridge introduced into the polylinker EcoRI site. Mutations were verified by DNA sequencing using the method of Sanger et al. [33] .
Enzyme purification
The recombinant enzyme was purified from Escherichia coli (DH5α) aerobically. The pelleted cells from batch cultures were resuspended (0n5 g wet wt.\ml) in buffer A (50 mM Tris\HCl, pH 8n0, 5 mM dithiothreitol and 10 µM ZnCl # ) containing 3 µg\ml lysozyme. The resuspended cells were incubated on ice for 30 min, frozen in liquid N # , thawed, and centrifuged for 30 min at 15 000 g. The clarified lysate was incubated at 85 mC for 15 min, cooled on ice for 30 min, and then centrifuged for 30 min at 15 000 g. (NH % ) # SO % (50 %, w\v) was added to the supernatant and stirred at 4 mC for 30 min. The 2m ADH was recovered from the supernatant after centrifugation for 30 min at 15 000 g and precipitated with stirring at 4 mC for 30 min in 70 % (w\v) (NH % ) # SO % . After centrifugation for 30 min at 15 000 g, the purified 2m ADH was resuspended in buffer A and stored at 4 mC.
Enzyme kinetics
The standard 2m ADH activity assay was defined as NADP + reduction coupled to propan-2-ol oxidation at 60 mC as previously described [17] . The enzyme was incubated at 55 mC for 15 min before activity determination. Tris buffer pH was adjusted at 25 mC to be 8n0 at 60 mC (thermal correction factor lk0n031 ∆pH\mC). Assays to determine K m (app) and V max (app) were conducted at 60 mC with substrate concentrations between 20i K m (app) and 0n2iK m (app). Kinetic parameters were calculated from non-linear best fits of the data to the Michaelis-Menten equation using Kinzyme software [34] on an IBM personal computer. Protein concentrations were measured using the bicinchoninic acid procedure (Pierce, Rockford, IL, U.S.A.). Kinetic parameter values were calculated from the meanpS.D. for at least three independent activity determinations.
Determination of Zn content, molecular mass and peptide sequence
2m ADH samples were dialysed against 50 mM NH % HCO $ , pH 8n0, containing 100 g\l Chelex resin (Bio-Rad, Hercules, CA, U.S.A.) for 12 h to remove unbound or adventitiously bound metals. The metal-cleared samples were concentrated to between 1n2 and 12 mg\ml using Centricon 30 ultrafiltration units (Amicon, Beverly, MA, U.S.A.) for inductively coupled plasmaatomic emission spectrometry (ICP-AES) analysis (Chemical Analysis Laboratory at the University of Georgia, Athens). Subunit molecular-mass values were determined by comparison with standards (Bio-Rad) using SDS\PAGE (12 % polyacrylamide). The error values for the N-terminal amino acid sequences of the recombinant 2m ADH protein population expressed from the pADHBKA4-kan plasmid were reported as standard deviations and were calculated on the basis of the relative abundances of the two amino acid species present at each of the first seven peptide positions.
XAS
The Zn-co-ordination environment was structurally characterized using EXAFS. Enzyme samples were concentrated to 1-10 mg\ml (" 0n1 mM Zn) in 50 mM Tris\HCl, pH 8n0 and stored in liquid N # before analysis. Zn EXAFS data were collected at the Stanford Synchrotron Radiation Laboratory (beamline 7-3) with the SPEAR ring operating at 3n0 GeV and 55-65 mA. Details of data collection and reduction were as follows : monochrometer crystal [Si(220)] ; fluorescence detection using a 13-element solid-state array ; data are the average of 16 scans (22 min) ; temperature, 10 K ; energy calibration, 9660n7 eV for the first inflection of the Zn foil spectrum ; E ! , 9670 eV ; pre-edge background energy range, 9333-9625 eV ; pre-edge background Gaussian centre (width l 1000 eV), 8713 eV ; spline background was a third-order polynomial from 9675 to 10366 eV with spline points at 9905 and 10136 eV.
EXAFS data were analysed by established techniques [35] using EXAFSPAK software (courtesy of G. N. George, Stanford, CA). Raw EXAFS data curve fitting to identify and quantify co-ordination by histidine imidazoles included single and multiple scattering paths 4n5 A H or less from the Zn atom. The geometry and orientation for an imidazole bond to Zn were fixed on the basis of those for the model compound Zn(imid)
. Theoretical scattering amplitudes and phase shifts for each scattering path containing four or fewer legs were calculated using FEFF v5.04 software [37] [38] [39] . These calculated parameters were used in a constrained curve-fitting process in which the numbers of Zn-co-ordinating atoms were limited to integer values. In fits with imidazoles as the only (N,O)-containing ligands, the distances and Debye-Waller factors for outer-shell imidazole rings were constrained to a given ratio with the firstshell (Zn-N) distance and Debye-Waller factor respectively. Similar FEFF-based analysis of data also collected at 10 K for model compounds containing M-imidazole (M l Ni, Cu, Zn) interactions yielded imidazole first-(Rh $ 2 A H ), second-(Rh $ 3 A H ) and third (Rh $ 4 A H ) shell σ as # values of 0n0020-0n0030 A H #, 0n0030-0n0050 A H # and 0n0040-0n0060 A H # respectively. Numerous fits using other first-shell (N,O)-containing ligands at distances indistinguishable from that for Zn-N imid were examined. In these fits, the Debye-Waller factor for the Zn-(N,O) first-shell was not constrained to be a particular ratio with the second-and thirdshell values since static disorder in such a mixed-ligand shell is expected to result in larger relative Debye-Waller σ as # values. Calibration with Zn(imid) [40] indicated accuracies within 0n02 A H for the firstshell distances reported here.
RESULTS
Enzyme overexpression
T. ethanolicus 2m ADH was purified from E. coli (DH5α) harbouring plasmid pADHBKA4-kan (Table 1 ) with a 67 % recovery. The recombinant enzyme was expressed at more than 10 % of total soluble protein without induction (Figure 1 ). This construct contained the native ribosome assembly site and translational initiation codons but lacked the native promoter regions, placing the gene under transcriptional control of the pBluescriptII KS(j) lacZ promoter. The recombinant protein population included 56p11 % enzyme with a duplicated Nterminal methionine (MMKGFA …) while 44p11 % of the protein possessed a single methionine at the N-terminus. Alteration of the ATGATG translational initiation site to TTAATG in the pADHB1M1-kan expression plasmid eliminated the synthesis of 2m ADH with two N-terminal methionines but altered neither the enzyme expression level compared with that seen with pADHBKA4-kan nor the enzyme specific activities toward ethanol and propan-2-ol. The K m (app) values toward propan-2-ol, ethanol and NADP + were 1n1p0n22 mM, 53p9n0 mM and 17p2n6 µM respectively for the enzyme expressed from pADHBKA4-kan and 0n87p0n32 mM, 37p4n2 mM and 8n5p 1n4 µM respectively for the enzyme expressed from pADHB1M1-kan.
Catalytic Zn ligation
Chemical-modification experiments have implicated Zn, Cys and His in T. ethanolicus 2m ADH activity. Peptide alignments identified Cys$(, His&* and Asp"&! as potential catalytic Zn ligands [28] . Zn XAS data of native 2m ADH (not shown) were identical with those for the recombinant wild-type 2m ADH (Figure 2) . Extraction of the raw XAS data for the recombinant wild-type enzyme by Fourier filtering of the first-shell FT peak, followed by single-shell curve-fitting, suggested a Zn(N,O) $ -% S " first coordination sphere (results not shown). Non-linear least-square fits to unfiltered smoothed EXAFS data (Figure 2b) allow estimation of the number of histidine imidazole ligands. Table 2 summarizes the results obtained assuming either one or two imidazole ligands. The negative Debye-Waller σ as # value for the Zn-S ligand and the unreasonably large Zn-C % and Zn-N $ σ as # values indicate that the co-ordination sphere oZn(imid) tested in fit 1 is physically improbable. The two-sulphur singleimidazole-containing co-ordination sphere modelled in fit 4 oZn(imid) " (N,O) # S # q is also an unlikely match to the 2m ADH Znliganding environment because of the unreasonably large Zn-S Debye-Waller α as # values. Although either fit 2 or 3 in Table 2 is reasonable, if two imidazoles are assumed (fit 2) the DebyeWaller σ as # values for outer shell scattering are 2-3-fold greater than those for the fit including a single imidazole (fit 3). Therefore, on the basis of this analysis, a 5-rather than a 4-co-ordinate Zn site of composition Zn(N,O) Table 2 ) is most consistent with the observed data (Figures 2b and 2c) .
Mutant adhB genes encoding substitutions of residues 37, 59 and 150 were constructed by PCR to test the involvement of these amino acids in catalytic Zn binding. Mutant proteins were expressed at levels similar to, and purified to homogeneity using the procedure described for, the recombinant wild-type enzyme. Sequencing the mutated section of the adhB gene confirmed the identity of each mutant. Excess Zn was removed from the protein samples by extensive dialysis against buffer containing metalchelating resin. Mutant and wild-type enzymes treated for Zn analysis were active and showed no increase in activity on addition of 10 µM Zn (results not shown) ; however, given the typically high affinities for enzyme catalytic metal binding, Zncontaminated assay components could have provided sufficient metal to reconstitute the mutant enzyme catalytic sites, explaining the observed activity. All Zn levels measured by ICP-AES were more than 100-fold higher than the background value. ICP-AES analysis indicated that the enzyme expressed from the wild-type gene (pADHBKA4-kan) and the single N-terminal Met mutant enzyme bound 0n47 and 0n50 Zn# + ions per subunit respectively. The C37S and H59N mutant enzymes contained less than 25 % of the Zn retained by the wild-type enzyme. Altering Asp"&! to Glu preserved the wild-type Zn level, whereas that in the D150N mutant was 70 % of wild-type. Changing the putative Asp"&! ligand to Cys increased bound Zn 2-fold. Finally, the Gly"*) to Asp mutation did not significantly alter 2m ADH Zn content. Point mutations altering Cys$(, His&* and Asp"&! significantly reduced enzyme V max (app) ( Table 3 ). The conservative Cys$( to Ser mutation replaced the putative Zn ligand residue with one less than 0n4 A H shorter. This mutant retained less than 1 % of the wild-type enzyme V max (app) toward both ethanol and propan-2-ol. Replacing His&* with Asn eliminated the ionizable nitrogen atom and reduced the enzyme V max (app) to less than 0n5 % of that of the wild-type. The D150C mutant, which presumably mirrored the Cys-His-Cys 1m ADH catalytic Zn-liganding motif, retained approx. 3 % of the wild-type enzyme activity, the highest specific activity among the catalytic Zn mutants. Replacing the Asp carboxy moiety with a thiol group preserved its strong negative ionic character but shortened the amino acid side chain by approx. 0n6 A H . Mutating Asp"&! to Glu also retained the electronic characteristics for metal binding but it lengthened the side chain approx. 1n3 A H . The V max (app) of this mutant was 0n2 % of the wild-type specific activity. Significantly reducing the polarity of this residue while maintaining wild-type geometry, the D150N mutant retained less than 1 % of the wild-type V max (app).
Cofactor and substrate specificity
On the basis of the hypothesis of a specific amino acid position responsible for NAD(H) versus NADP(H) cofactor specificity in Rossmann-fold-containing proteins [41] , our 1m ADH-2m ADH peptide alignment [28] predicts that mutating Gly"*) in the T. ethanolicus 2m ADH peptide to Asp would exclude NADP(H) from the cofactor-binding site but allow NAD(H) binding. The wild-type enzyme had a 140-fold lower K m (app) for NADP + than for NAD + and a catalytic efficiency for propan-2-ol oxidation 2400-fold greater using NADP + than using NAD + (Table 4) . Replacing Gly"*) with Asp increased the K m (app) for NADP + 225-fold and reduced the V max (app) using NADP + 4-fold. The mutant enzyme had a 3-fold lower K m (app) toward NAD + and a 5n5-fold higher propan-2-ol-oxidation rate using NAD + compared with wild-type, giving the mutant a 6n7-fold lower catalytic efficiency for NADP + -linked propan-2-ol oxidation than for the NAD + -dependent reaction. In contrast with the G198D mutant, all of the enzymes containing mutations to the putative catalytic Zn-ligand residues had high affinities for NADP + [K m (app) values less than 40 µM (Table 3) ]. The high K m (app) and low V max (app) values using NAD + measured for these mutants were similar to those for the wild-type 2m ADH (results not shown).
Mutational effects on 2m ADH affinity for 1m compared with 2m alcohol substrates and on the catalytic efficiencies for oxidizing these substrates indicate a role for the putative catalytic Zn ligands in substrate specificity and in catalytic rate enhancement. Mutating Cys$( to Ser increased the K m (app) values for propan-2-ol and ethanol 6-fold and 20-fold respectively (Table 3) . Determining the K m (app) for ethanol of the C37S mutant was complicated by our inability to measure enzyme initial rates using substrate concentrations greater than 700 mM and lower than 300 mM. This K m (app) value is reported for completeness, but it is an approximate value and is not included in subsequent data analysis. Replacing His&* with Asn caused a 6-fold increase in the K m (app) toward propan-2-ol and no significant change in the K m (app) toward ethanol. The K m (app) for propan-2-ol of the D150C mutant was similar to the wild-type value and that for ethanol was increased only 2-fold. Mutating Asp"&! to Glu caused a 3-fold increase in the K m (app) for ethanol but a 29-fold increase in the K m (app) toward propan-2-ol. Finally, the D150N mutant had a K m (app) toward propan-2-ol 5-fold lower than the wild-type and a K m (app) toward ethanol 4-fold greater than the wild-type enzyme. The catalytic efficiencies of all mutants were lower than those of the wild-type enzyme but, for each mutant enzyme, the ratio of the catalytic efficiencies for propan-2-ol versus with ethanol oxidation varied from 4-fold lower (the D150E mutant) to 10-fold higher (the D150N mutant) than that calculated for the wild-type enzyme.
DISCUSSION
The research described here provides direct evidence for the involvement of specific amino acid residues in T. ethanolicus 39E 2m ADH catalysis. The presence of a single specifically bound Zn# + ion in the enzyme subunit and the identities of at least two of the three potential liganding protein residues were confirmed by EXAFS analysis. ICP-AES data for the wild-type and mutant enzymes implicated Cys$(, His&* and Asp"&! in catalytic Zn binding. Kinetic measurements of mutant enzymes implicated Cys$(, His&* and Asp"&! in both catalytic rate enhancement and substrate specificity. Transforming the highly NADP(H)-specific T. ethanolicus 2m ADH into an NAD(H)-preferring enzyme with the Gly"*) to Asp mutation further validated the sequence comparisons between 1m and 2m ADH, provided experimental evidence that this 2m ADH binds its nicotinamide cofactor in a Rossmann fold, and made the T. ethanolicus enzyme more suitable as an industrial biocatalyst. Furthermore construction of the overexpression system provided sufficient yield of purified enzyme for structural analysis and potential industrial-scale biocatalyst production.
The original T. ethanolicus 39E 2m ADH gene was expressed in E. coli DH5α under the control of its own promoter at approx. 2 % of total protein [28] . In E. coli this construct generated a mixed 2m ADH population containing single and double Nterminal methionines, unlike the homogeneous single N-terminal methionine-containing population isolated from T. ethanolicus. Removing the native promoter region, placing the adhB gene under the control of the pBLuescriptII KS(j) lacZ promoter (in the pADHBKA4-kan construct), increased the 2m ADH expression to more than 10 % of total protein. High-level expression of a homogeneous 2m ADH population containing a nativeenzyme-like single N-terminal methionine was then achieved by modifying the pADHBKA4-kan adhB translational initiation ATGATG region to TTAATG (pADHB1M1-kan). A simplified purification procedure using only heat-treatment and (NH % ) # SO % precipitation reduced enzyme losses to 33 % while eliminating time-consuming and costly chromatography steps. The similar kinetic results reported here for the homogeneous and mixed recombinant enzyme populations and those reported previously for enzyme isolated from T. ethanolicus and the mixed recombinant protein [28] indicate that neither the additional Met residue nor its codon is needed for expression or processing of recombinant enzyme to a catalytically native-like 2m ADH. Expressing high levels of this homogeneous 2m ADH population and its isolation to extreme purity has allowed crystallographic studies for three-dimensional structural determination [19] . Economical recombinant 2m ADH production will also make the development of this enzyme as a commercial biocatalyst for chiral compound synthesis and racemate resolution [1] [2] [3] [4] [5] [6] 23] more feasible.
The prediction that Gly"*) was in part responsible for T. ethanolicus 2m ADH NADP(H) specificity was based on the hypothesis that the cofactor was bound in a Rossmann fold [28] . Consistent with the prediction from the hypothesis of Wierenga and Hol [41] that replacing Gly"*) with a negatively charged Asp residue would repel the added NADP + phosphate moiety, this mutation dramatically decreased the affinity of 2m ADH for NADP + . However, mutating Gly"*) to Asp only increased the enzyme affinity for NAD + 3-fold which is still a 48-fold lower affinity than the wild-type enzyme for NADP + . The mutant showed a 16 000-fold increase in the ratio of the catalytic efficiencies for NAD + ersus NADP + reduction but the V max (app) of the mutant using either NAD + or NADP + was lower than that of the wild-type enzyme for NADP + -dependent catalysis, suggesting that the G198D mutant-cofactor complex is suboptimal for turnover. Therefore, beyond agreement with the general prediction, the high mutant 2m ADH NAD(H) K m (app) and low V max (app) values indicate that other enzyme structural features contribute to NAD(H) ersus NADP(H) binding and discrimination. This first experimental evidence that 2m ADHs bind cofactor in a Rossmann fold also generated the first thermophilic 2m ADH having higher catalytic efficiency using the more thermally stable NAD(H) cofactor.
With few exceptions, 1m ADHs require an enzyme-bound catalytic Zn# + ion, liganded by two Cys residues and a single His residue [7] . The EXAFS data presented here identified a Zn# + ion specifically bound to a co-ordination sphere oZnS "
including oxygen ligands plus a T. ethanolicus 2m ADH cysteine sulphur and imidazole nitrogen. This is similar to the coordination sphere reported for the 1m ADH catalytic Zn but inconsistent with the four cysteine sulphurs that co-ordinate the 1m ADH structural Zn [7] . The low ICP-AES measured Zn content ( 1 per subunit) also supports the predicted lack of a 1m ADH-like polycysteine-liganded structural Zn in 2m ADHs [27, 28] . These EXAFS and ICP-AES analyses of the wild-type recombinant enzyme identifying a specifically bound Zn provide direct experimental evidence supporting the sequence-and chemical inactivation-based prediction that the T. ethanolicus 2m ADH contains a catalytic Zn [28] . However, kinetic analyses of sitedirected 2m ADH mutants are required to identify the amino acid ligands and to confirm the catalytic importance of this bound metal. Peptide alignments of 1m and 2m ADHs identified T. ethanolicus 2m ADH residues Cys$( and His&* as being analogous to two of the liver 1m ADH catalytic Zn ligands [24] . These alignments placed Asp"&! (conserved in 2m ADHs) in the sequence position corresponding to the second catalytic Zn-Cys ligand of liver 1m ADH. The nearest 2m ADH Cys residue to this position is Cys#!$, C-terminal to the Rossmann-fold residue Gly"*). Although a Cys-His-Asp Zn-binding motif has not been reported for ADHs, it has been described for sorbitol dehydrogenases [42] . Mutating Cys$( to Ser, His&* to Asn or Asp"&! to Asn eliminated them as potential Zn ligands and reduced enzyme activity to less than 1 % of wild-type, implicating them in catalysis. The molar ratios of bound Zn per subunit for these mutants were 4-fold, 4-fold and 1n4-fold lower respectively than that for the wild-type enzyme, implicating them in Zn binding. The lack of a substantial change in bound metal as a result of the Gly to Asp mutation at position 198 (predicted to be unrelated to catalytic Zn liganding by sequence alignment and its demonstrated effect on cofactor specificity) further underscores the significance of the reduced Zn content measured for these position-37, -59 and -150 mutants. Altering Asp"&! to Glu indicated that maintaining the electronic nature of the Asp side chain preserved Zn binding, but the mutant's dramatically reduced V max (app) (0n2 % of wild-type) suggested that the position of the carboxylate was critical to catalysis. The D150C mutant, designed to create the 1m ADHlike Cys-His-Cys catalytic Zn-binding motif, doubled the molar ratio of enzyme-liganded Zn, implicating this residue in Zn binding by enhancing rather than diminishing metal content. The K m (app) values resulting from this spatially conservative mutation were also less than those for the D150E mutant, suggesting that the metal position is important to enzyme affinity for substrate. Whether ICP-AES measured 2m ADH Zn-binding stoichiometry (one Zn per dimer) or gauged the enzyme's Zn affinity relative to that of the Chelex resin under the dialysis conditions does not alter the conclusion that 2m ADH affinity for Zn is specifically affected by non-conservative mutations at positions 37, 59 and 150. The ICP-AES measurements indicating that 10-100 % of the five position-37, -59 and -150 mutant protein subunits bound metal after dialysis and the altered enzyme affinities for substrates also suggest that the low specific activities displayed by these mutants ( 3 % of wild-type V max (app) using either substrate) did not result simply from the loss of metal. Although analysis of this Zn-binding motif by EXAFS measurements of the mutant proteins or crystallographic determination of the 2m ADH three-dimensional structure is necessary to elucidate the enzyme-metal stoichiometry and the liganding structural details (both of these studies are underway), the EXAFS, ICP-AES and kinetic data reported here clearly support the hypothesis that T. ethanolicus 2m ADH residues Cys$(, His&* and Asp"&! ligate a catalytic Zn. Because horse liver 1m ADH is so well characterized, it is an excellent reference for predicting other ADH structures. 1m and 2m ADH peptide sequence comparisons have suggested that, although similarities exist, these enzyme groups may lack extensive structural similarity in catalytically important regions [27, 28] . The data presented here demonstrate that the T. ethanolicus 2m ADH is a Zn-dependent Rossmann-fold-containing enzyme that uses a Cys-His-Asp metal-binding motif. Thus, by comparison with the liver 1m ADH (Figure 3a) , we propose the hypothetical working model for 2m ADH structure-function studies depicted in Figure 3(b) . The kinetic mechanisms proposed for catalysis by both horse liver [7] and T. brockii [43] ADHs require bound cofactor before substrate binding. Analysis of the horse liver 1m ADH three-dimensional structure [24] suggests that the cofactor may function to complete the active-site cavity wall. Therefore, as in the liver 1m ADH active site, the nicotinamide cofactor may complete 2m ADH catalytic pocket formation. The His&* and Asp"&! mutations altered the 2m ADH K m (app) for propan-2-ol over a 140-fold range, whereas the overall change in affinity for ethanol spanned a range of only 7-fold. The greater sensitivity of 2m ADH secondary-alcohol binding to Zn ligand mutations suggests that the substrate binds the catalytic Zn atom, as in the liver 1m ADH [7] . The physiological acetyl-CoAlinked reductive thioesterase activity for the T. ethanolicus 2m ADH also suggested that the long lobe of the previously proposed two-lobe active site [1] may be open-ended, allowing the CoA portion of the substrate to remain outside [17] . Analogously, the active-site channel in horse liver ADH has a closed short segment and a long segment open at the far end, with the catalytic Zn atom at their junction [24] . This may represent a structural similarity between 1m and 2m ADH architectures related to substrate specificity that is also of potential biotechnological importance. Finally, the data presented here indicate that comparative analysis between the two enzyme classes may yield further insights into both 1m and 2m ADH molecular structurefunction relationships and obtaining an exact 2m ADH structure will provide the additional information needed to rigorously evaluate these hypotheses.
We gratefully acknowledge Maris Laivenieks for assistance in protein purification. Drs. Claire Vieille, Cindy Petersen and Lloyd Hough provided helpful discussions and assistance with 2m ADH molecular biology. X-ray absorption studies in the RAS laboratory are supported by the National Institute of Health (GM42025). The XAS data were collected at the Stanford Synchrotron Radiation Laboratory (SSRL), which is operated by the Department of Energy, Division of Chemical Sciences. The SSRL
